Hologic Continues 2021 Spending Spree With $795M Acquisition Of Mobidiag
Mobidiag develops molecular diagnostic tests and instrumentation that will expand Hologic’s acute care testing capabilities.
You may also be interested in...
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Hologic’s recent buy-outs put it in a strengthened growth and competitive position beyond COVID.
Hologic’s acquisition of Somatex Medical will expand its biopsy portfolio and direct channel in Germany.